Bioforce Nanosciences Holdings (BFNH) Other Operating Expenses (2020 - 2026)

Bioforce Nanosciences Holdings (BFNH) has 7 years of Other Operating Expenses data on file, last reported at $105750.0 in Q1 2026.

• Quarterly Other Operating Expenses changed 0.0% year-over-year to $105750.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $317250.0 (down 25.0% YoY) and the FY2024 annual result came in at $423000.0, changed 0.0% from the prior year.
• Other Operating Expenses steadied at $105750.0 in Q1 2026, from $105750.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $105750.0 in Q2 2022 to a low of $6283.0 in Q1 2022.
• A 5-year average of $99533.3 and a median of $105750.0 in 2022 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2022 — Other Operating Expenses slumped 94.06% — and 2023, when it surged 1583.11%.
• Tracing BFNH's Other Operating Expenses over 5 years: stood at $105750.0 in 2022, then changed by 0.0% to $105750.0 in 2023, then changed by 0.0% to $105750.0 in 2024, then changed by 0.0% to $105750.0 in 2025, then changed by 0.0% to $105750.0 in 2026.
• The last three Other Operating Expenses figures came in at $105750.0 (Q1 2026), $105750.0 (Q3 2025), and $105750.0 (Q2 2025), per Business Quant data.